| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000063236A3 Adhesion modulatory peptides and methods for use |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | US20010005592 Chondrocyte-like cells useful for tissue engineering and methods |
| 06/28/2001 | US20010005591 Production of megakaryocytes by the use of human mesenchymal stem cells |
| 06/28/2001 | US20010005590 Culturing time is shortened and the expression types of the cultivated cells are stably manifested; side effect reduction; using chondrocytes; antiarthritic agents; osteoarthritis |
| 06/28/2001 | US20010005589 A DNA having promoter activity of Tec tyrosine kinase and a vector incoporating the promoter to obtain a high level of expression of an exogenous gene in hematopoietic stem cells and hepatic cells; gene therapy |
| 06/28/2001 | US20010005586 High speed selective identification, indivisual targeting with an energy beam, specific cells within a cell population for the purpose of inducing a response in the targeted cells, without affecting cells that are not being targeted |
| 06/28/2001 | US20010005581 Assay for screening agents that alter angiogenesis |
| 06/28/2001 | US20010005506 Producing a disease-specific immunogenic cell by isolating CD34 negative hematopoietic stem cells, incubating in culture medium with colony stimulating factor, and interleukin-4 to develop into programmable antigen presenting cells (pAPC's) |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19960843A1 Wurzelspezifischer Promotor Root-specific promoter |
| 06/28/2001 | DE19958693A1 Verfahren und Zusammensetzungen zur Herstellung von Zelltransplantaten Methods and compositions for the production of cell transplants |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | DE10036175A1 Determining activity of nucleic acid, useful for optimizing therapeutic or diagnostic nucleic acids, by transforming organisms, in parallel, with many different sequences |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395286A1 Aspartyl proteases |
| 06/28/2001 | CA2395269A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 06/28/2001 | CA2395245A1 Macroporous chitosan beads and preparation method thereof |
| 06/28/2001 | CA2395239A1 Rna polymerases from bacteriophage phi 6-phi 14 and use thereof |
| 06/28/2001 | CA2395228A1 Pathologically modified myocardial cell, production and use thereof |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395102A1 Human kinases |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394812A1 A method to produce cloned embryos and adults from cultured cells |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394743A1 Inhibition of .beta.arrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia |
| 06/28/2001 | CA2394741A1 Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions |
| 06/28/2001 | CA2394614A1 Embryonic or stem-like cells produced by cross species nuclear transplantation |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393646A1 Survivin promotion of angiogenesis |
| 06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
| 06/28/2001 | CA2392827A1 Double selection vector |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2392712A1 Multifunctional recombinant phycobiliprotein-based fluorescent constructs and phycobilisome display |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/27/2001 | EP1111061A1 Double selection vector |
| 06/27/2001 | EP1111060A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 06/27/2001 | EP1111059A1 A novel human lysozyme gene, its encoding polypeptide and the method preparing for them |
| 06/27/2001 | EP1111058A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
| 06/27/2001 | EP1111056A2 Process for activating a kinase |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111051A1 Promoter for guard cell-specific gene expression in plants |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111043A1 New QTL's on chromosomes X, 2, 6 and 7 of pigs |
| 06/27/2001 | EP1111040A1 Infection of eukaryotic cells with viruses in vitro |
| 06/27/2001 | EP1111039A1 Immature autologous clinical grade dendritic cells intended for vaccination of cancer patients |
| 06/27/2001 | EP1110970A1 Anti-Procalcitonin antibody, their production and use |
| 06/27/2001 | EP1109921A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
| 06/27/2001 | EP1109920A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 06/27/2001 | EP1109919A2 Rationally designed heparinases derived from heparinase i and ii |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP1109917A2 Human transferase proteins |
| 06/27/2001 | EP1109916A1 Nucleic acid molecules encoding an amylosucrase |
| 06/27/2001 | EP1109911A2 Staphylococcus aureus genes and polypeptides |
| 06/27/2001 | EP1109908A2 Leptin induced genes |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109901A2 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
| 06/27/2001 | EP1109895A1 Endothelial cell proliferation inhibitors derived from human prothrombin |
| 06/27/2001 | EP1109894A1 Recombinant vanadium haloperoxidases and their uses |
| 06/27/2001 | EP1109892A2 Methods for generating high titer helper-free preparations of released recombinant aav vectors |
| 06/27/2001 | EP1109891A1 Method for producing cloned cows |
| 06/27/2001 | EP1109890A1 Method for producing human cloned embryos by employing inter-species nuclear transplantation technique |
| 06/27/2001 | EP1109888A1 Enhanced submucosal tissue graft constructs |
| 06/27/2001 | EP1109887A1 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
| 06/27/2001 | EP1109833A2 Compositions and methods for the treatment of tumors |
| 06/27/2001 | EP1109829A1 Human latent transforming growth factor beta binding protein 3 |
| 06/27/2001 | EP1109822A1 Factor 8 homologue nucleic acids, polypeptides, methods, uses |
| 06/27/2001 | EP1109821A1 49 human secreted proteins |
| 06/27/2001 | EP1109818A1 Phosphoepoxides, method for making same and uses |
| 06/27/2001 | EP1109817A1 Phosphohalohydrins, method for making same and uses |
| 06/27/2001 | EP1109582A1 Methods to enhance and confine expression of genes |
| 06/27/2001 | EP1109578A1 Modulation of endothelial cell surface receptor activity in the regulation of angiogenesis |
| 06/27/2001 | EP1109570A2 Method of modulating memory effector t-cells and compositions |
| 06/27/2001 | EP1109569A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 06/27/2001 | EP1109566A1 Gcp |
| 06/27/2001 | EP1109565A1 Gabab1aa receptor |
| 06/27/2001 | EP0725800B1 cDNA ENCODING A NOVEL HUMAN PROTEIN TYROSINE PHOSPHATASE |
| 06/27/2001 | EP0701554B1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 06/27/2001 | CN1301311A Detection of DNA, RNA and proteins |
| 06/27/2001 | CN1301307A Methods for producing polypeptides in filamentous fungal mutant cells |
| 06/27/2001 | CN1301304A Fatty acyl-CoA: fatty alcohol acyltransferases |
| 06/27/2001 | CN1301300A Pollen specific promoter |
| 06/27/2001 | CN1301299A production of biofilaments in transgenic animals |
| 06/27/2001 | CN1301297A Medium and method for viral propagation and growth |